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Accepted 13 October 2011Allogeneic hematopoietic stem cell transplantation
(AHSCT) is being used to treat hematological malignancies
with increasing frequency. AHSCT has many complications,
such as infections, veno-occlusive disease of the liver, drug
reactions, and graft-versus-host disease (GvHD). Pathogenesis
of GvHD is believed to be a complex immune response,
primarily T-cell mediated, in which the grafted donor cells
recognize the host as foreign. GvHD can involve the skin,
gastrointestinal tract, lungs, and liver [1]. It is a difficult-to-
diagnose disease that gynecologists may not be familiar
with. Our case gives guidance on the prevention and
management of the gynecologic complications of GvHD.
A 44-year-old, gravida 2, para 2 woman had been diag-
nosed with chronic myeloid leukemia 4 years earlier, and was
treated with imatinib and hydroxyurea for 1 year. She had also
suffered from dysmenorrhea 4 years earlier and had
a 3 2 cm2 left ovarian cyst that suggested endometriosis.
After entering complete remission, she underwent AHSCT.
One year after the AHSCT, she developed chronic GvHD with
pulmonary organ involvement and began menopause. Her
laboratory findings revealed a follicle-stimulating hormone
level of 49 IU and estradiol (E2) of 19. Sequential hormone
replacement therapy was introduced for the menopause
symptoms.
Subsequently, she presented with a 5-day history of
abdominal pain. Clinical examination revealed extensive
vulvar atrophy with flattening. She had almost complete
obstruction of the entire vaginal canal (Fig. 1). Vaginal biop-
sies revealed chronic nonspecific inflammation with fibrosis.
We performed the human papillomavirus (HPV) DNA chip
test to screen for precancerous risk factors. The test was
positive for HPV (other type) in the vagina. Vaginal stenosis
limited the ability to perform a routine Papanicolaou test and* Corresponding author. Department of Obstetrics and Gynecology, Soon-
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hematocolpos (Fig. 2).
Computed tomography (CT) revealed that the vaginal canal
and uterus were filled with a heterogeneous, high-density
hematoma (Fig. 3). We dilated the vagina and performed
a hysteroscopic-guided biopsy of the endometrium. The
pathology revealed chronic nonspecific inflammation of the
vagina and endometrium. Six months after vaginal dilation,
a Papanicolaou test of the cervix revealed atypical squamous
cells of undetermined significance. Postoperatively, she was
treated with topical immunosuppressive therapy and vaginal
dilators. Six months later, the Papanicolaou test revealed low-
grade squamous intraepithelial lesions, and the HPV DNA
chip test was positive for HPV 62. She progressed to
obstruction of the vaginal canal and abdominal pain. We
performed a total abdominal hysterectomy. The pathology
revealed cervical intraepithelial neoplasia, grade I (HPV
infection). We present a woman who developed hematocolpos
as a complication of chronic GvHD after AHSCT.
GvHD remains a major complication in AHSCT patients
[2]. Classically, GvHD has been classified as acute and chronicFig. 1. Photograph shows almost complete obstruction of the entire vaginalcanal.
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Fig. 3. Computed tomography scan shows that the vaginal canal and uterus were filled with a heterogeneous, high-density hematoma.
Fig. 2. Ultrasonography shows hematometra with hematocolpos.
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days after the transplant or later. Currently, the number of days
after the transplant is not sufficient to differentiate acute from
chronic GvHD [2]. Chronic GvHD is the most common
complication after transplantation, described in 60e80% of
patients. Chronic GvHD is more heterogeneous in its mani-
festations, and many of the symptoms resemble those of
autoimmune disorders [3]. Skin involvement is reported in
more than 90% of the cases. Gynecologic manifestations of
chronic GvHD are rare and may be underestimated. Because
mild chronic GvHD of the vulva or vagina may occasionally
be asymptomatic and detected only on examination, gyneco-
logic care is need in AHSCT [4].
Regarding the gynecologic care, first, the genital area is
best cleaned with warm water rather than with soap or femi-
nine wash products [4]. Second, if symptoms such as dysuria,
dryness, tenderness to touch, and dyspareunia develop, we
prescribe topical estrogen therapy prophylactically to preventthe progression of local symptoms. Third, hormone replace-
ment therapy is recommended when menopause is confirmed,
although this can contribute to the formation of hema-
tocolpometra in the presence of vaginal synechiae progression,
such as in our case. Finally, management of GvHD may
require vaginal dilatation, local corticotherapy, and estrogen
therapy, as in our case. Surgery is indicated in advanced cases
to restore the normal anatomy [5]. In some cases, laparoscopy
may be considered to exclude endometriosis that is obstructing
the menstrual flow occurring as a result of vaginal stenosis [6].
Systemic immunosuppressive therapy is also indicated for
vulvovaginal GvHD that progresses or fails to improve after
treatment with local measures [4]. Hematologists, physicians,
and oncologists are interested in chronic GvHD. Nevertheless,
the gynecologist should provide counseling and examine the
vagina and pelvis regularly to prevent vagina and vulvar GvHD.References
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